These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Toxoplasmosis in Poznan region, Poland 1990-2000]. Pawłowski ZS Przegl Epidemiol; 2002; 56(3):409-17. PubMed ID: 12608090 [TBL] [Abstract][Full Text] [Related]
3. [Toxoplasmosis--epidemiology, clinical manifestation and infection in pregnant women]. Biesiada G; Kalinowska-Nowak A; Czepiel J; Mach T Przegl Lek; 2006; 63(2):97-9. PubMed ID: 16969908 [TBL] [Abstract][Full Text] [Related]
4. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis]. Paul M Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926 [TBL] [Abstract][Full Text] [Related]
5. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia. Gallego-Marín C; Henao AC; Gómez-Marín JE J Trop Pediatr; 2006 Apr; 52(2):107-12. PubMed ID: 16014760 [TBL] [Abstract][Full Text] [Related]
6. Cord blood screening for congenital toxoplasmosis: detection and treatment of asymptomatic newborns in Basel, Switzerland. Berger R; Stürchler D; Rudin C Scand J Infect Dis Suppl; 1992; 84():46-50. PubMed ID: 1290074 [TBL] [Abstract][Full Text] [Related]
7. Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: the experience in Poznań, Poland. Pawlowski ZS; Gromadecka-Sutkiewicz M; Skommer J; Paul M; Rokossowski H; Suchocka E; Schantz PM Health Educ Res; 2001 Aug; 16(4):493-502. PubMed ID: 11525395 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Cornu C; Bissery A; Malbos C; Garwig R; Cocherel C; Ecochard R; Peyron F; Wallon M Euro Surveill; 2009 Mar; 14(9):21-5. PubMed ID: 19317970 [TBL] [Abstract][Full Text] [Related]
11. Prevention of congenital toxoplasmosis in Austria. Aspöck H Arch Pediatr; 2003 Feb; 10 Suppl 1():16-7. PubMed ID: 12802957 [No Abstract] [Full Text] [Related]
12. [The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw]. Niemiec KT; Raczyński P; Markiewicz K; Leibschang J; Ceran A Wiad Parazytol; 2002; 48(3):293-9. PubMed ID: 16888975 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of congenital toxoplasmosis: official recommendations and management in France]. Thiebaugeorges O; Schweitzer M Arch Pediatr; 2003 Feb; 10 Suppl 1():20. PubMed ID: 12802960 [No Abstract] [Full Text] [Related]
15. Screening for toxoplasmosis during pregnancy: the situation in Belgium. Naessens A Arch Pediatr; 2003 Feb; 10 Suppl 1():18. PubMed ID: 12802958 [No Abstract] [Full Text] [Related]
16. [Analysis of complications during pregnancy in women with serological features of acute toxoplasmosis or acute parvovirosis]. Marcinek P; Nowakowska D; Szaflik K; Spiewak E; Małafiej E; Wilczyński J Ginekol Pol; 2008 Mar; 79(3):186-91. PubMed ID: 18592853 [TBL] [Abstract][Full Text] [Related]
17. [Prenatal biological diagnosis of congenital toxoplasmosis: value and limits]. Pelloux H Arch Pediatr; 2003 Feb; 10 Suppl 1():33-4. PubMed ID: 12802967 [No Abstract] [Full Text] [Related]
18. [Epidemiological data on toxoplasmosis. The aspects of congenital toxoplasmosis]. Crucerescu E Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):147-55. PubMed ID: 9932003 [TBL] [Abstract][Full Text] [Related]
19. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? Eskild A; Oxman A; Magnus P; Bjørndal A; Bakketeig LS J Med Screen; 1996; 3(4):188-94. PubMed ID: 9041483 [TBL] [Abstract][Full Text] [Related]
20. [Prevention of congenital toxoplasmosis in a Buenos Aires hospital]. Carral L; Kaufer F; Olejnik P; Freuler C; Durlach R Medicina (B Aires); 2013; 73(3):238-42. PubMed ID: 23732199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]